# Periocular necrotizing fasciitis

**Authors:** Zaynab Somani, Hyun Jun Kim, Andrew Harrison, Ali Mokhtarzadeh

PMC · DOI: 10.3389/fopht.2026.1758717 · Frontiers in Ophthalmology · 2026-01-26

## TL;DR

Periocular necrotizing fasciitis is a severe infection that can lead to serious complications, and early diagnosis and treatment are crucial for better outcomes.

## Contribution

This mini-review synthesizes current evidence for treating periorbital necrotizing fasciitis and highlights emerging diagnostic and therapeutic approaches.

## Key findings

- Early surgical debridement and intravenous antibiotics are standard treatments for PNF.
- Emerging blood biomarkers and hypochlorous irrigation may improve diagnosis and outcomes.
- Treatment decisions for PNF remain debated due to risks of vision loss and disfigurement.

## Abstract

Necrotizing fasciitis is a rapidly progressive infection commonly associated with group A Streptococci and other toxin-producing bacteria that leads to microvascular thrombosis, tissue ischemia, and fascial plane spread. Although the periorbital region’s rich vascularity and natural anatomic barriers help limit deep extension and systemic spread, periorbital necrotizing fasciitis (PNF) can cause septicemia, systemic toxicity, and death. Early diagnosis is critical but remains challenging; distinguishing PNF from inflammatory mimics such as Sweet’s syndrome is critical given their opposing interventions. Surgical debridement along with intravenous antibiotics remain the cornerstone of treatment. However, considering the significant morbidity from vision loss and disfigurement, the decision to pursue early surgical debridement versus conservative management remains an area of active debate. Emerging blood biomarkers may aid diagnosis, and adjunctive therapies, including hypochlorous irrigation, show promise in improving outcomes of PNF while minimizing treatment-associated morbidities. This mini-review synthesizes current treatment evidence for PNF, integrating findings from PNF-focused literature and studies of generalized-NF at other anatomical sites. While principles utilized in the treatment of generalized NF may be applicable to PNF, exact statistics may vary by anatomic site.

## Linked entities

- **Diseases:** necrotizing fasciitis (MONDO:0004835)

## Full-text entities

- **Diseases:** NF (MESH:D016518), ischemia (MESH:D007511), death (MESH:D003643), Necrotizing fasciitis (MESH:D019115), inflammatory (MESH:D007249), thrombosis (MESH:D013927), Sweet's syndrome (MESH:D016463), infection (MESH:D007239), vision loss (MESH:D014786), toxicity (MESH:D064420), septicemia (MESH:D018805)
- **Species:** Streptococcus sp. 'group A' (species) [taxon 36470], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12883387/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12883387/full.md

---
Source: https://tomesphere.com/paper/PMC12883387